The Necessity of Addressing Cost Burden on Patients

Drug prices may not be sustainable, but what really matters is not the price of the drug, but what the cost is to patients, said Ted Okon, executive director of the Community Oncology Alliance, and Daniel Klein, president and executive director of the Patient Access Network (PAN) Foundation, during a panel at the University of Michigan Center for Value-Based Insurance Design (V-BID), V-BID Summit, held March 13 in Ann Arbor, Michigan.